The Asthma Impairment and Risk Questionnaire (AIRQ®) Predicts Exacerbation Risk in Patients With Mild-to-Moderate and Severe Disease
Year: 2024
Type: conference-abstract
Institutions: New York University, Capital Allergy and Respiratory Disease Center, National Jewish Health, Kaiser Permanente, Kaiser Permanente San Diego Medical Center, Johns Hopkins University, Johns Hopkins Medicine, Columbia University, AstraZeneca (United States), Boys Town National Research Hospital
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4396502501
